Your browser doesn't support javascript.
loading
A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.
van Zuydam, Natalie R; Ahlqvist, Emma; Sandholm, Niina; Deshmukh, Harshal; Rayner, N William; Abdalla, Moustafa; Ladenvall, Claes; Ziemek, Daniel; Fauman, Eric; Robertson, Neil R; McKeigue, Paul M; Valo, Erkka; Forsblom, Carol; Harjutsalo, Valma; Perna, Annalisa; Rurali, Erica; Marcovecchio, M Loredana; Igo, Robert P; Salem, Rany M; Perico, Norberto; Lajer, Maria; Käräjämäki, Annemari; Imamura, Minako; Kubo, Michiaki; Takahashi, Atsushi; Sim, Xueling; Liu, Jianjun; van Dam, Rob M; Jiang, Guozhi; Tam, Claudia H T; Luk, Andrea O Y; Lee, Heung Man; Lim, Cadmon K P; Szeto, Cheuk Chun; So, Wing Yee; Chan, Juliana C N; Ang, Su Fen; Dorajoo, Rajkumar; Wang, Ling; Clara, Tan Si Hua; McKnight, Amy-Jayne; Duffy, Seamus; Pezzolesi, Marcus G; Marre, Michel; Gyorgy, Beata; Hadjadj, Samy; Hiraki, Linda T; Ahluwalia, Tarunveer S; Almgren, Peter; Schulz, Christina-Alexandra.
Afiliação
  • van Zuydam NR; Wellcome Centre Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, U.K. nvanzuy@well.ox.ac.uk.
  • Ahlqvist E; Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, U.K.
  • Sandholm N; Diabetes and Endocrinology, Department of Clinical Sciences, Lund University, Malmö, Sweden.
  • Deshmukh H; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.
  • Rayner NW; Abdominal Center Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Abdalla M; Diabetes and Obesity Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland.
  • Ladenvall C; Newcastle University, Newcastle, U.K.
  • Ziemek D; Wellcome Centre Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, U.K.
  • Fauman E; Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, U.K.
  • Robertson NR; Human Genetics Programme, Wellcome Sanger Institute, University of Cambridge, Cambridge, U.K.
  • McKeigue PM; Wellcome Centre Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, U.K.
  • Valo E; Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, U.K.
  • Forsblom C; Department of Statistics, University of Oxford, Oxford, U.K.
  • Harjutsalo V; Diabetes and Endocrinology, Department of Clinical Sciences, Lund University, Malmö, Sweden.
  • Perna A; Computational Target Validation, Pfizer, Cambridge, MA.
  • Rurali E; Wellcome Centre Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, U.K.
  • Marcovecchio ML; Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, U.K.
  • Igo RP; Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, U.K.
  • Salem RM; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.
  • Perico N; Abdominal Center Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Lajer M; Diabetes and Obesity Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland.
  • Käräjämäki A; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.
  • Imamura M; Abdominal Center Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Kubo M; Diabetes and Obesity Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland.
  • Takahashi A; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.
  • Sim X; Abdominal Center Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Liu J; Diabetes and Obesity Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland.
  • van Dam RM; Chronic Disease Prevention Unit, National Institute for Health and Welfare, Helsinki, Finland.
  • Tam CHT; Clinical Research Center for Rare Diseases "Aldo e Cele Daccò," Istituto di Ricerche Farmacologiche "Mario Negri," Bergamo, Italy.
  • Luk AOY; Clinical Research Center for Rare Diseases "Aldo e Cele Daccò," Istituto di Ricerche Farmacologiche "Mario Negri," Bergamo, Italy.
  • Lee HM; Department of Paediatrics, University of Cambridge, Cambridge, U.K.
  • Lim CKP; Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH.
  • Szeto CC; Department of Family Medicine and Public Health, University of California, San Diego, San Diego, CA.
  • So WY; Clinical Research Center for Rare Diseases "Aldo e Cele Daccò," Istituto di Ricerche Farmacologiche "Mario Negri," Bergamo, Italy.
  • Chan JCN; Steno Diabetes Center Copenhagen, Gentofte, Denmark.
  • Ang SF; Diabetes Center, Vaasa Health Care Center, Vaasa, Finland.
  • Dorajoo R; Department of Advanced Genomic and Laboratory Medicine, Graduate School of Medicine, University of the Ryukyus, Nishihara, Japan.
  • Wang L; Division of Clinical Laboratory and Blood Transfusion, University of the Ryukyus Hospital, Nishihara, Japan.
  • Clara TSH; RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • McKnight AJ; RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Duffy S; Department of Genomic Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.
  • Pezzolesi MG; Saw Swee Hock School of Public Health, National University of Singapore, Singapore.
  • Marre M; Division of Human Genetics, Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore.
  • Gyorgy B; Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Hadjadj S; Saw Swee Hock School of Public Health, National University of Singapore, Singapore.
  • Hiraki LT; Department of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
  • Ahluwalia TS; Department of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
  • Almgren P; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China.
  • Schulz CA; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong, China.
Diabetes ; 67(7): 1414-1427, 2018 07.
Article em En | MEDLINE | ID: mdl-29703844

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Diabetes Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Diabetes Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Estados Unidos